Traitements3programmes
Essais2liés
Publications7liées
SourceDBlocale

Traitements

3
MoléculeIndication / populationPhaseObjectifPaysRésultat
escitalopramThe purpose of this study is to see if escitalopram (Lexapro) improves symptoms of major depressive disorder in patients who have ALS or MS. Alzheimer, Sclérose latérale amyotrophique Phase 3 Traitement symptomatique United States À vérifier
escitalopramThe purpose of this study is to see if escitalopram (Lexapro) improves symptoms of major depressive disorder in patients who have ALS or MS. Sclérose latérale amyotrophique Phase 3 Traitement symptomatique United States À vérifier
escitalopramThe purpose of this study is to see if escitalopram (Lexapro) improves symptoms of major depressive disorder in patients who have ALS or MS. Alzheimer Phase 4 Traitement symptomatique Israel À vérifier

Essais cliniques

2
MoléculeIndication / populationPhaseNCTTitreStatut
escitalopram Alzheimer Phase 4 NCT01119638 EscBPSD — Escitalopram Treatment for BPSD in Alzheimer's Disease in Comparison to Risperidone COMPLETED
escitalopram Sclérose latérale amyotrophique Phase 3 NCT00965497 Escitalopram (Lexapro) for Depression MS or ALS COMPLETED

Publications

7
MoléculeIndication / populationTitreJournalDate
escitalopram Uncovering Modifiable Contributors to Depressive Symptoms During Antidepressant Prescription Renewal: A Primary Care Case Report. Clinical case reports
escitalopram Sertraline and Escitalopram But Not Other Antidepressants Increase Acetylcholinesterase Activity in the Rat Frontal Cortex. Annals of neurosciences
escitalopram Large-scale analysis demonstrates the influence of CYP2C19 genotype on specific SSRI side effects. The pharmacogenomics journal
escitalopram Generalizable structure-function covariation predictive of antidepressant response revealed by target-oriented multimodal fusion. Nature. Mental health
escitalopram Effect of anti-anxiety therapy on the prognosis of patients with atrial fibrillation and anxiety: a 2 × 2 factorial randomized controlled trial. Frontiers in cardiovascular medicine
escitalopram Pharmacovigilance Analysis of Bleeding Events Associated With Selective Serotonin Reuptake Inhibitors (SSRIs) Using the US Food and Drug Administration Adverse Event Reporting System (FAERS). Cureus
escitalopram Correlation of Illicit Opioid Use With Antidepressants in Adults Receiving Buprenorphine/Naloxone: An Exploratory Analysis. Substance use & addiction journal